Advanced search
Publication Cover
Regenerative Medicine Volume 4, 2009 - Issue 3
Submit an article Journal homepage
6,910
Views
0
CrossRef citations to date
0
Altmetric
Review

Novel Sources of Fetal Stem Cells: Where do they Fit on the Developmental Continuum?

Kalliopi I Pappa1 First Department of Obstetrics & Gynecology, University of Athens School of Medicine, Athens, Greece;2 Laboratory of Biology, University of Athens School of Medicine, Athens, Greece;3 Cell & Gene Therapy Laboratory, Centre of Basic Research, Foundation for Biomedical Research of the Academy of Athens (IIBEAA), Athens, GreeceCorrespondence[email protected]
View further author information
&
Nicholas P Anagnou2 Laboratory of Biology, University of Athens School of Medicine, Athens, Greece;3 Cell & Gene Therapy Laboratory, Centre of Basic Research, Foundation for Biomedical Research of the Academy of Athens (IIBEAA), Athens, GreeceView further author information
Pages 423-433 | Published online: 13 May 2009

Bibliography

  • Klimanskaya I , RosenthalN, LanzaR: Derive and conquer: sourcing and differentiating stem cells for therapeutic applications.Nat. Rev. Drug Discov.7 , 131–142 (2008).
  • Hemberger M , YangW, NataleDet al.: Stem cells from fetal membranes. A Workshop Report.Placenta22 , S17–S19 (2008).
  • Guillot PV , GotherstromC, ChanJ, KurataH, FiskNM: Human first trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC.Stem Cells25 , 646–654 (2007).
  • DeCoppi P , BartschG Jr, Siddiqui MM et al.: Isolation of amniotic stem cells with potential for therapy. Nat. Biotech.25 , 100–106 (2007).
  • Roubelakis MG , PappaKI, BitsikaVet al.: Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells.Stem Cells Dev.16 , 931–952 (2007).
  • Kim J , LeeY, KimHet al.: Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells.Cell Prolif.40 , 75–90 (2007).
  • Tsai MS , LeeJL, ChangYJ, HwangSM: Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol.Hum. Reprod.19 , 1450–1456 (2004).
  • Tsai MS , HwangSM, TsaiYL, ChengFC, LeeJL, ChangYJ: Clonal amniotic fluid-derived cells express characteristics of both mesenchymal and neural stem cells.Biol. Reprod.74 , 545–551 (2006).
  • Bossolasco P , MontemurroT, CovaLet al.: Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential.Cell Res.16 , 329–336 (2006).
  • Prusa AR , MartonE, RosnerM, BernaschekG, HengstschlägerM: Oct-4 expressing cells in human amniotic fluid: a new source for stem cell research?Hum. Reprod.18 , 1489–1493 (2003).
  • Prusa AR , MartonE, RosnerMet al.: Neurogenic cells in human amniotic fluid.Am. J. Obstet. Gynecol.191 , 309–314 (2004).
  • Perin L , SedrakyanS, Da Sacco S, De Filippo R: Characterization of human amniotic fluid stem cells and their pluripotential capacity. Methods Cell Biol.86 , 85–99 (2008).
  • Zhao P , IseH, HongoM, OtaM, KonishiI, NikaidoT: Human amniotic mesenchymal cells have some characteristics of cardiomyocytes.Transplantation79 , 528–535 (2005).
  • Kolambkar YM , PeisterA, SokerS, AtalaA, GuldbergRE: Chondrogenic differentiation of amniotic fluid-derived stem cells.J. Mol. Histol.38 , 405–413 (2007).
  • Kunisaki SM , ArmantM, KaoGS, StevensonK, KimH, FauzaDO: Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials.J. Pediatr. Surg.42 , 974–980 (2007).
  • Sessarego N , ParodiA, PodestàMet al.: Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application.Haematologica93 , 339–346 (2008).
  • Tsai MS , HwangSM, ChenKDet al.: Functional network analysis on the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow.Stem Cells25 , 2511–2523 (2007).
  • Sartore S , LenziM, AngeliniAet al.: Amniotic mesenchymal cells autotransplanted in a porcine model of cardiac ischemia do not differentiate to cardiogenic phenotypes.Eur. J. Cardiothorac. Surg.28 , 677–684 (2005).
  • Chiavegato A , BolliniS, PozzobonMet al.: Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat.J. Mol. Cell. Cardiol.42 , 746–759 (2007).
  • Pan HC , YangDY, ChiuYTet al.: Enhanced regeneration in injured sciatic nerve by human amniotic mesenchymal stem cell.J. Clin. Neurosci.13 , 570–575 (2006).
  • Schmidt D , AchermannJ, OdermattBet al.: Prenatally fabricated autologous human living heart valves based on amniotic fluid-derived progenitor cells as single cell source.Circulation116 , S64–S70 (2007).
  • De Coppi P , CallegariA, ChiavegatoAet al.: Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells.J. Urol.117 , 369–376 (2007).
  • Broxmeyer HE , SrourE, OrschellCet al.: Cord blood stem cell and progenitor cells.Methods Enzymol.419 , 439–473 (2006).
  • Broxmeyer HE : Biology of cord blood cells and future prospects for enhanced clinical benefit.Cytotherapy7 , 209–218 (2005).
  • Mazurier F , DoedensM, GanOI: Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells.Nat. Med.9 , 953–963 (2003).
  • McNiece IK , Almeida-ParadaG, ShpallEJ: ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential.Exp. Hematol.30 , 612–616 (2002).
  • Stier S , ChengT, DombkowskiD: Notch-1 activation increases hemopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome.Blood99 , 2369–2378 (2002).
  • Reya T , DuncanAW, AillesL: A role for Wnt signaling in self-renewal of haematopoietic stem cells.Nature423 , 409–414 (2003).
  • Tao W , BroxmeyerHE: Towards a molecular understanding of hematopoietic stem cell and progenitor cells. In: Cord Blood: Biology, Immunology, Banking, and Clinical Transplantation. Broxmeyer HE (Ed.). American Association of Blood Banking, Bethesda, MD, USA 87–123 (2004).
  • Wang JF , WangLJ, WuYF: Mesenchymal stem/progenitor cells in human umbilical cord blood as support for in vivo expansion of CD34+ hematopoietic stem cells and for chondrogenic differentiation.Haematologica89 , 837–844 (2004).
  • Javazon EH , BeggsKJ, FlakeAW: Mesenchymal stem cells: paradoxes of passaging.Exp. Hematol.32 , 414–425 (2004).
  • McGuckin CP , ForrazN, AllouardQ, PettengelR: Umbilical cord blood stem cells can expand hematopoietic and neuroglial progenitors in vitro.Exp. Cell Res.295 , 350–359 (2004).
  • Sanchez-Ramos J : Stem cells from human umbilical cord blood.Sem. Reprod. Med.24 , 358–369 (2006).
  • Koponen JK , KekarainenT, HeinonenSEet al.: Umbilical cord blood-derived progenitor cells enhance muscle regeneration in mouse hindlimb ischemia model.Mol. Ther.15 , 2172–2177 (2007).
  • Tondreau T , MeulemanN, DelforgeAet al.: Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity.Stem Cells23 , 1105–1112 (2005).
  • Greco SJ , LinK, RameshwarP: Functional similarities among genes regulated by Oct4 in human mesenchymal and embryonic stem cells.Stem Cells25 , 3143–3154 (2007).
  • McGuckin CP , ForrazN, BaradezMOet al.: Production of stem cells with embryonic characteristics from human umbilical cord blood.Cell Prolif.38 , 245–255 (2005).
  • Zhao Y , WangH, MazzoneT: Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics.Exp. Cell Res.312 , 2454–2464 (2006).
  • Markov V , KusumiK, TadesseMet al.: Identification of cord blood-derived mesenchymal stem/stromal cell populations with distinct growth kinetics, differentiation potentials, and gene expression profiles.Stem Cells Dev.16 , 53–73 (2007).
  • Sun B , RohKH, LeeSR, LeeYS, KangKS: Induction of human umbilical cord blood-derived stem cells with embryonic stem cell phenotypes into insulin producing islet-like structure.Biochem. Biophys. Res. Commun.354 , 919–923 (2007).
  • Lee OK , KuoTK, ChenWM, LeeKD, HsiehSL, ChenTH: Isolation of multipotent mesenchymal stem cells from umbilical cord blood.Blood103 , 1669–1675 (2004).
  • Reinisch A , BartmannC, RohdeEet al.: Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application.Regen. Med.2 , 371–382 (2008).
  • Chang YJ , ShihDT, TsengCP, HsiehTB, LeeDC, HwangSM: Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood.Stem Cells24 , 679–685 (2006).
  • Chang YJ , TsengCP, HsuLF, HsiehTB, HwangSM: Characterization of two populations of mesenchymal progenitor cells in umbilical cord blood.Cell Biol. Int.30 , 495–499 (2006).
  • Weiss ML , MedicettyS, BledsoeARet al.: Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson‘s disease.Stem Cells24 , 781–792 (2006).
  • Sarugaser R , LickorishD, BakshD, HosseiniMM, DaviesJE: Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors.Stem Cells23 , 220–229 (2005).
  • Karahuseyinoglou S , CinarO, KilicEet al.: Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys.Stem Cells25 , 319–331 (2007).
  • Mitchell KE , WeissML, MitchellBMet al.: Matrix cells from Wharton‘s jelly form neurons and glia.Stem Cells21 , 50–60 (2003).
  • Wang HS , HungSC, PengSTet al.: Mesenchymal stem cells in the Wharton‘s jelly of the human umbilical cord.Stem Cells22 , 1330–1337 (2004).
  • Takechi K , KuwabaraY, MizunoM: Ultrastructural and immunohistochemical studies of Wharton‘s jelly umbilical cord cells.Placenta14 , 235–245 (1993).
  • Fu YS , ChengYC, LinMYet al.: Conversion of human umbilical cord mesenchymal stem cells in Wharton‘s jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism.Stem Cells24 , 115–124 (2006).
  • Carlin R , DavisD, WeissM, SchultzB, TroyerD: Expression of early transcription factors Oct4, Sox2 and Nanog by porcine umbilical cord (PUC) matrix cells.Reprod. Biol. Endocrinol.4 , 8 (2006).
  • Conconi MT , BurraP, Di Liddo R et al.: CD105+ cells from Wharton‘s jelly show in vitro and in vivo myogenic differentiation potential. Int. J. Mol. Med.18 , 1089–1096 (2006).
  • Ilancheran S , MichalskaA, PehG, WallaceEM, PeraM, ManuelpillaiU: Stem cells derived from human fetal membranes display multilineage differentiation potential.Biol. Reprod.77 , 577–588 (2007).
  • Miki T , MitamuraK, RossMA, StolzDB, StromSC: Identification of stem cell marker-positive cells by immunofluoresence in term human amnion.J. Reprod. Immunol.75 , 91–96 (2007).
  • Miki T , StromSC: Amnion-derived pluripotent/multipotent stem cells.Stem Cell Rev.2 , 133–142 (2006).
  • Marcus AJ , CoyneTM, RauchJ, WoodburyD, BlackIB: Isolation, characterization and differentiation of stem cells derived from the rat amniotic membrane.Differentiation76 , 130–144 (2008).
  • Alviano F , FossatiV, MarchionniCet al.: Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro.BMC Dev. Biol.7 , 11 (2007).
  • Tamagawa T , OiS, IshiwataI, IshikawaH, NakamuraY: Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro.Hum. Cell20 , 77–84 (2007).
  • Wolbank S , PeterbauerA, FahrnerMet al.: Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue.Tissue Eng.13 , 1173–1183 (2007).
  • Keating A : How do mesenchymal stromal cells suppress T cells?Cell Stem Cell2 , 106–108 (2008).
  • Parolini O , AlvianoF, BagnaraGPet al.: Isolation and characterization of cells from human term placenta: outcome of the First International Workshop on Placenta-Derived Stem Cells.Stem Cells26 , 300–311 (2008).
  • Wen F , TynanJA, CecenaGet al.: Ets2 is required for trophoblast stem cell self-renewal.Dev. Biol.312 , 284–299 (2007).
  • Battula VL , TremlS, AbeleH, BühringHJ: Prospective isolation and characterization of mesenchymal stem cells from human placenta using a frizzled-9-specific monoclonal antibody.Differentiation76 , 326–336 (2008).
  • Strakova Z , LivakM, KrezalekM, IhnatovychI: Multipotent properties of myofibroblasts cells derived from human placenta.Cell Tissue Res.332 , 479–488 (2008).
  • Kim SJ , SongCH, SungHJet al.: Human placenta-derived feeders support prolonged undifferentiated propagation of a human embryonic stem cell line, SNUhES3: comparison with human bone marrow-derived feeders.Stem Cells Dev.16 , 421–428 (2007).
  • Miao Z , JinJ, ChenLet al.: Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells.Cell Biol. Int.30 , 681–687 (2006).
  • Li C , ZhangW, JiangX, MaoN: Human placenta-derived mesenchymal stem cells inhibit proliferation and function of allogeneic immune cells.Cell Tissue Res.330 , 437–446 (2007).
  • Jones BJ , BrookeG, AtkinsonK, McTaggartSJ: Immunosuppression by placental indoleamine 2,3-dioxygenase: a role for mesenchymal stem cells.Placenta28 , 1174–1181 (2007).
  • Li D , WangGY, DongBH, ZhangYC, WangYX, SunBC: Biological characteristics of human placental mesenchymal stem cells and their proliferative response to various cytokines.Cells Tissues Organs186 , 169–179 (2007).
  • Battula VL , BareissPM, TremlSet al.: Human placenta and bone-marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation.Differentiation75 , 279–291 (2007).
  • Fukuchi Y , NakajimaH, SugiyamaD, HiroseI, KitamuraT, TsujiK: Human placenta-derived cells have mesenchymal stem/progenitor cell potential.Stem Cells22 , 649–658 (2004).
  • In‘t Anker PS , ScherjonSA, Kleijburg-van der Keur C et al.: Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells22 , 1338–1345 (2004).
  • Portmann-Lanz CB , SchoeberleinA, HuberAet al.: Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration.Am. J. Obstet. Gynecol.194 , 664–673 (2006).
  • Yen BL , ChienCC, ChenYCet al.: Placenta-derived multipotent cells differentiate into neuronal and glial cells in vitro.Tissue Eng. Part A14 , 9–17 (2008).
  • Chang CM , KaoCL, ChangYLet al.: Placenta-derived multipotent stem cells induced to differentiate into insulin-positive cells.Biochem. Biophys. Res. Commun.357 , 414–420 (2007).
  • Chien CC , Yenn Bl, Lee FK et al.: In vitro differentiation of human placenta-derived multipotent cells into hepatocyte-like cells. Stem Cells24 , 1759–1768 (2006).
  • Schmidt D , MolA, BreymannCet al.: Living autologous heart valves engineered from human prenatally harvested progenitors.Circulation114 , S125–S131 (2006).
  • Zhang HJ , SiuMKY, WongESY, WongKY, LiASM, ChanKYK: Oct-4 is epigenetically regulated by methylation in normal placenta and gestational trophoblastic disease.Placenta29 , 549–554 (2008).
  • Wu CC , ChaoYC, ChenCNet al.: Synergism of biochemical and mechanical stimuli in the differentiation of human placenta-derived multipotent cells into endothelial cells.J. Biomech.41 , 813–821 (2008).
  • Lang I , SchweizerA, HiddenUet al.: Human fetal placenta endothelial cells have a mature arterial and a juvenile venous phenotype with adipogenic and osteogenic differentiation potential.Differentiation76 , 1031–1043 (2008).
  • Brooke G , TongH, LevesqueJP, AtkinsonK: Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta.Stem Cells Dev.17 , 929–940. (2008).
  • Prather WR , TorenA, MeironM: Placental-derived and expanded mesenchymal stromal cells (PLX-I) to enhance the engraftment of hematopoietic stem cells derived from umbilical cord blood.Expert Opin. Biol. Ther.8 , 1241–1250 (2008).
  • Kim JS , RomeroR, TarcaAet al.: Gene expression profiling demonstrates a novel role for fetal fibrocytes and the umbilical vessels in human fetoplacental development.J. Cell. Mol. Med.12 , 1317–1330 (2008).
  • Chen CP , LeeMY, HuangJPet al.: Trafficking of multipotent mesenchymal stromal cells from maternal circulation through the placenta involves vascular endothelial growth factor-1 and integrins.Stem Cells26 , 550–561 (2008).
  • Rhodes KE , GekasC, WangYet al.: The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation.Cell Stem Cell2 , 252–263 (2008).
  • Soupene E , SerikovV, KuypersFA: Characterization of an acyl-coenzyme A binding protein predominantly expressed in human primitive progenitor cells.Lipid Res.49 , 1103–1112 (2008).
  • Mao JL , KurmanRJ, HuangCC, LinMC, ShihIEM: Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis.Am. J. Surg. Pathol.31 , 1726–1732 (2007).
  • Daley GQ , HyunI, LindvallO: Mapping the road to the clinical translation of stem cells.Cell Stem Cell2 , 139–140 (2008).
  • Jaenisch R , YoungR: The molecular circuitry of pluripotency and nuclear reprogramming.Cell132 , 567–582 (2008).
  • Rossant J : Stem cells and early lineage development.Cell132 , 527–531 (2008).
  • Emanuel P : AFS cells – where do they fit on the continuum?The Hematologist: ASH News and Reports4 , 1 (2007).
  • Gilbert SF : The early development of vertebrates. In: Developmental Biology (8th Edition). Sinauer Associates, Inc., MA, USA 353 (2006).
  • Gilbert SF , TylerAL, ZackinEJ: Bioethics and the New Embryology: Springboards for the Debate. Sinauer Associates, Inc., MA, USA 20 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.